Asymchem Laboratories Tianjin Co (SZSE:002821) 5-Year EBITDA Growth Rate : 44.40% (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Asymchem Laboratories Tianjin Co 5-Year EBITDA Growth Rate?

Asymchem Laboratories Tianjin Co's EBITDA per Share for the three months ended in Mar. 2024 was ¥0.80.

During the past 12 months, Asymchem Laboratories Tianjin Co's average EBITDA Per Share Growth Rate was -43.70% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 41.20% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 44.40% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 31.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Asymchem Laboratories Tianjin Co was 68.80% per year. The lowest was 14.50% per year. And the median was 31.00% per year.

Competitive Comparison of Asymchem Laboratories Tianjin Co's 5-Year EBITDA Growth Rate

For the Biotechnology subindustry, Asymchem Laboratories Tianjin Co's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Asymchem Laboratories Tianjin Co's 5-Year EBITDA Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Asymchem Laboratories Tianjin Co's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Asymchem Laboratories Tianjin Co's 5-Year EBITDA Growth Rate falls into.

Asymchem Laboratories Tianjin Co 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Asymchem Laboratories Tianjin Co (SZSE:002821) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

Asymchem Laboratories Tianjin Co 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Asymchem Laboratories Tianjin Co's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Asymchem Laboratories Tianjin Co (SZSE:002821) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Asymchem Laboratories Tianjin Co Ltd (SZSE:002821) » Definitions » 5-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

06821:Hong Kong 7K90:Germany

Address

No. 6 Dongting Third Street, Economic and Technological Development Zone, Tianjin, CHN, 300457

Website

https://www.asymchem.com

Asymchem Laboratories Tianjin Co Ltd is a China-based company, a technology-driven provider of Contract Development Manufacture Organization solutions throughout the drug development and manufacturing process. The Group provides clinical-stage CDMO solutions, commercial-stage CDMO solutions, and emerging services. Its operations relate to contract development and manufacturing which focuses on innovation and commercial application of global pharmaceutical technology.

Executives

Xiao Yi	Executives
Xu Xiang Ke	Directors, executives
Zhou Yan	Executives
Chen Chao Yong	Executives
Huang Xiao Lian	Executives
Yang Jing	Director
	Executives

Asymchem Laboratories Tianjin Co (SZSE:002821) Headlines

No Headlines